- Austria (Website)
- Czech Republic (Website)
- Denmark (Website)
- Finland (Website)
- France (Website)
- Germany (Website)
- Italy (Website)
- Ivory Coast
bioMérieux Signature Event: Fort Lauderdale
Join bioMérieux for a robust educational evening with key opinion leaders to gain a better understanding of the integral role rapid results reporting plays in patient care decisions and Antimicrobial Stewardship initiatives in your hospital.
Professional Acknowledgment for Continuing Education® (P.A.C.E.®) credits will be offered.
The Laboratory plays a critical role in delivering timely, actionable results to physicians and pharmacists. Learn the true value of these rapid results and how clinicians use them to aid in the decision-making process for patient treatment. Our featured speakers will provide real-world examples of how to utilize ID/AST systems and leverage workflow optimization in your facility to aid in rapid reporting of results — all of which can have a significant impact on patient care and antimicrobial stewardship programs!
Registration for this event is now closed.
Schedule of Events
|5:00 - 6:00 pm||Registration and networking reception|
|6:00 - 9:30 pm||Featured presentations including dinner|
Speakers & Topics
|Vincent LaBombardi, PhD
Director of Microbiology, Immunology and Medical Microbiology at New York Presbyterian, Queens, NY
Dr. LaBombardi will discuss the use of VITEK® Advanced Expert System™ as an aid in the clinical management of patients by describing current resistance mechanisms found among bacteria and how they are plaguing US hospitals. He will also review how phenotypic antimicrobial profiles aid in the determination of antibiotic resistance in clinical bacterial isolates and explain the role of auto-posting ID/AST results in achieving the goal of rapid reporting.
|Kim Wait, MT (ASCP)
Manager, Laboratory Optimization, bioMérieux, Inc., Durham, NC
The laboratory is constantly challenged to do more with less. Lean principles are essential to maximizing efficiencies, streamlining processes, leveraging best practices, and achieving measurable results in your facility. Mrs. Wait will review these principles and discuss how to optimize your current ID/AST workflow to decrease time to result, reduce waste, and improve quality throughout your laboratory.
|Mike Broyles, PharmD
Director of Pharmacy and Laboratory Services at Five Rivers Medical Center, Pocahontas, AR
Dr. Broyles will utilize patient case studies to showcase how clinicians and pharmacists use laboratory results to help guide antibiotic therapy and improve clinical outcomes. He’ll also discuss laboratory modalities that are useful in the management of patients with infections and how these modalities can positively affect antimicrobial stewardship initiatives in your facility.
Dr. Vince LaBombardi received his Ph.D in microbial biochemistry from St. John’s University in New York. He did his training in clinical microbiology at Queens Hospital Center where he stayed on as Associate Chief of Microbiology. He subsequently moved to St. Vincent’s Medical Center in New York City where he stayed for 18 years as the Chief of Clinical Microbiology. He then became the Director of Microbiology at Mount Sinai Medical Center in New York where he also held the rank of Associate Professor of Pathology at the Mount Sinai School of Medicine. He currently serves as the Director of Microbiology, Immunology and Medical Microbiology at New York Presbyterian Queens. Dr. LaBombardi is a past president of the New York City Branch of the American Society for Microbiology, and past president of the New York Mycology Society. He served for many years on the editorial board of the Journal of Clinical Microbiology. Dr. LaBombardi has published widely in the field of clinical microbiology and infectious disease. He also lectures nationally and internationally in the areas of Mycobacteriology, antibiotic resistance and stewardship.
Kim Wait is the manager of the Laboratory Optimization consultant team at bioMérieux. Kim received her training at West Virginia University where she completed her B.S. degree in Medical Technology and MT (ASCP) certification. Before joining bioMérieux in 2012, she was the Assistant Administrative Director of the Clinical Microbiology/Immunology & Molecular Pathology Laboratories at UNC Hospitals in Chapel Hill, North Carolina retiring after 30 years of service. Since beginning her consultant career at bioMérieux, Kim has participated in over 90 projects in 84 different Microbiology Laboratories in 32 states and 2 foreign countries.
Dr. Mike Broyles is a Doctorate Prepared Pharmacist with more than 25 years of experience as a Hospital Pharmacy Director and Laboratory Director providing patients with current concepts in the clinical use of drugs, with more than 18 years consulting for a large IDN as their pharmacy advisory chairman to develop and implement clinical initiatives. Dr. Broyles has consulted for more than a dozen IDN’s, Thermo Fisher Scientific, Roche Diagnostics, bioMérieux, Roche Diagnostics, Alaris Medical, Carefusion, ICNet and independently serving hospitals from 35 to 1200 beds in size. Projects include TheraTrac 2, Stellara, ABX Alert, TheraDoc, coagulation, sepsis management, and antimicrobial stewardship programs including those using the biomarker procalcitonin to reduce antimicrobial exposure. His goal is to provide the leading thought processes in patient management and use technology to enhance the ability of clinicians to have the best options in patient’s clinical status, decision support and documentation to improve outcomes.